Risperidone-SABER® | UCB
UCB's Global Corporate Website

Risperidone-SABER®

Disease area studied Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available)
Schizophrenia A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia Phase 1 ZX003-1101
Completed
NCT01592110
Schizophrenia Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia Phase 1 ZX003-1401
Completed
NCT02411526